Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07581483 · ClinicalTrials.gov registry record · NA

Reciprocal Innovation to Optimize Low-Tech Augmentative and Alternative Communication (AAC) for Individuals

A NA study, sponsored by Indiana University.

Not yet
Registry status
NA
Development phase
500
Enrollment target

NCT07581483: Clinical Trial NA study, sponsored by Indiana University.

NCT07581483 is a NA study that has not yet begun recruiting, run by Indiana University. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07581483, a NA study, has not yet begun recruiting, sponsored by Indiana University.

NOT YET RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target

Study Summary

Many people with autism and other developmental conditions have difficulty speaking or do not use speech and need other ways to communicate. Augmentative and alternative communication (AAC) includes tools such as picture boards, communication books, and gestures that support communication. In low-resource settings and underserved rural areas in the United States, high-tech AAC devices are often too expensive or difficult to access, and trained specialists are limited. Low-tech AAC options are more affordable but are often not used successfully because tools may not match the individual's abilities or daily environment, caregivers and providers may lack training, and stigma or low awareness may discourage use. These challenges can lead to AAC abandonment and social isolation. Rural Virginia and western Kenya face similar barriers, including limited AAC expertise, inconsistent assessment, and insufficient training for families, educators, and community providers. This project uses a shared learning approach that combines western Kenya's experience implementing low-tech AAC in new settings with rural Virginia's expertise in individualized assessment, training, and scalable service delivery. The goal is to better match individuals to appropriate low-tech AAC systems and support communication partners to use them effectively.

Primary Outcome

Change in child functional communication, measured by the Communication Matrix total score. The Communication Matrix assesses intentional communication behaviors across communication functions and modalities.

Interventions

  • BEHAVIORAL Automated AAC Assessment and Low-Tech AAC Implementation Support
  • BEHAVIORAL Standard AAC Support

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2027-06-01
Est. Completion 2032-06-01
Phase NA
Indiana University

890 total trials

What is known before NCT07581483 opens enrollment

NCT07581483 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).

The record links to 0 conditions, and to 2 interventions - of which Automated AAC Assessment and Low-Tech AAC Implementation Support is the first listed.

NCT07581483 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07581483 about?

NCT07581483 is a clinical study titled "Reciprocal Innovation to Optimize Low-Tech Augmentative and Alternative Communication (AAC) for Individuals". Many people with autism and other developmental conditions have difficulty speaking or do not use speech and need other ways to communicate. Augmentative and alternative communication (AAC) includes tools such as picture boards, communication books, and gestures that support communication. In low-re...

What is the current status of trial NCT07581483?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2027-06-01. Estimated completion is 2032-06-01.

What interventions are being tested in trial NCT07581483?

The interventions under investigation include: Automated AAC Assessment and Low-Tech AAC Implementation Support (BEHAVIORAL), Standard AAC Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT07581483?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07581483's enrollment target sits among peer trials

500 193rd of 2000 higher than 1,788 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07581483, the US trial registry maintained by the National Library of Medicine. NCT07581483 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.